Interventional Technologies
This article was originally published in The Gray Sheet
Executive Summary
Firm's LP Stent coronary stent system, premounted on a compliant polyethylene delivery balloon, gains CE mark clearance for European marketing. Available in lengths ranging from 8-38 mm and diameters of 2-4 mm, the device alone received the CE mark in December 1998. The device is chemically milled using a photographic-mask-and-etch process similar to that used for electronic printed circuits, yielding a stent of "unsurpassed smoothness and strength," the company maintains. The firm submitted an investigational device exemption in April for U.S. trials
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.